禾盛平台 娱乐

    <sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

    <sub id="5vrrv"></sub><thead id="5vrrv"><var id="5vrrv"><mark id="5vrrv"></mark></var></thead>

      <address id="5vrrv"><listing id="5vrrv"></listing></address>

      <form id="5vrrv"></form>

      <address id="5vrrv"><listing id="5vrrv"></listing></address><sub id="5vrrv"><var id="5vrrv"><mark id="5vrrv"></mark></var></sub>

          <sub id="5vrrv"><var id="5vrrv"><ins id="5vrrv"></ins></var></sub><sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

          <sub id="5vrrv"><dfn id="5vrrv"></dfn></sub>

          <sub id="5vrrv"><var id="5vrrv"><output id="5vrrv"></output></var></sub>

          <form id="5vrrv"><nobr id="5vrrv"></nobr></form>

          <sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

            <address id="5vrrv"><dfn id="5vrrv"></dfn></address>

            <address id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></address>

            Key laboratory 

            In March 2011, the application of our university for the State Key Laboratory of Natural Medicines was successfully approved after many rounds of defenses and on-site investigation, upgrading the key lab construction level of our university.

             

            Technical macro-platform

              
            Based on overall construction of nearly three years, we have set up a comprehensive technical macro-platform of new-drug research and development, including such special platforms as pharmacokinetics, screening and preparation. Aimed at three disease categories (cardiovascular, tumor and diabetes), we have set up a batch of technically-advanced pharmacodynamic research models. In addition, in connection with the four key techniques undertaken by our university, we have set up a cluster of key techniques with an extremely strong service function. While serving manufacturing-teaching-research alliances and incubation bases, we have been conducting research and development of various drugs for critical diseases in cooperation with enterprises, having made an active contribution to the development of Chinese pharmaceutical enterprises.

             

              <sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

              <sub id="5vrrv"></sub><thead id="5vrrv"><var id="5vrrv"><mark id="5vrrv"></mark></var></thead>

                <address id="5vrrv"><listing id="5vrrv"></listing></address>

                <form id="5vrrv"></form>

                <address id="5vrrv"><listing id="5vrrv"></listing></address><sub id="5vrrv"><var id="5vrrv"><mark id="5vrrv"></mark></var></sub>

                    <sub id="5vrrv"><var id="5vrrv"><ins id="5vrrv"></ins></var></sub><sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

                    <sub id="5vrrv"><dfn id="5vrrv"></dfn></sub>

                    <sub id="5vrrv"><var id="5vrrv"><output id="5vrrv"></output></var></sub>

                    <form id="5vrrv"><nobr id="5vrrv"></nobr></form>

                    <sub id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></sub>

                      <address id="5vrrv"><dfn id="5vrrv"></dfn></address>

                      <address id="5vrrv"><dfn id="5vrrv"><mark id="5vrrv"></mark></dfn></address>

                      金皇朝2

                      ld乐动|体育|网址

                      网信的彩主页

                      pt游戏平台官网

                      江苏福彩网首页

                      大赢家网即时比分

                      彩赢娱乐平台

                      好运网站

                      赌博|下载